en

PRODUCT DETAIL

ROPINSTAD retard 2 mg

Code 4064A
MA number 27/0038/13-S
Product Form: tbl plg 98x2 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BC Dopamine agonists
N04BC04 Ropinirole
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 06.02.2013
Pediatric posology: Yes
PIL: PIL_ROPINSTAD retard_08.2023.pdf  
SPC: SPC_ROPINSTAD retard_08.2023.pdf  
Safety feature Yes
Data update: 21.08.2018
eu-flag.png sk-flag.png